Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes

Kang,Ok-Hwa; Kim,Sung-Bae; Mun,Su-Hyun; Seo,Yun-Soo; Hwang,Hyeong-Chil; Lee,Young-Mi; Lee,Ho-Seob; Kang,Dae-Gil; Kwon,Dong-Yeul

doi:10.3892/ijmm.2015.2074

Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes

Authors:
- Ok-Hwa Kang
- Sung-Bae Kim
- Su-Hyun Mun
- Yun-Soo Seo
- Hyeong-Chil Hwang
- Young-Mi Lee
- Ho-Seob Lee
- Dae-Gil Kang
- Dong-Yeul Kwon
View Affiliations

Affiliations: Department of Oriental Pharmacy, College of Pharmacy, Wonkwang Oriental Medicines Research Institute, Institute of Biotechnology, Wonkwang University, Iksan, Jeonbuk 570-749, Republic of Korea, BK21 Plus Team, Professional Graduate School of Oriental Medicine, Wonkwang University, Iksan, Jeonbuk 570-749, Republic of Korea
Published online on: January 21, 2015 https://doi.org/10.3892/ijmm.2015.2074
Pages: 803-809

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Non-alcoholic fatty liver disease (NAFLD) is characterized by the hepatic manifestation of metabolic syndrome and is the leading cause of chronic liver disease. Steatohepatitis plays a critical role in the process resulting in liver fibrosis and cirrhosis. Puerarin is a herbal product widely used in Asia, and is believed to have therapeutic benefits for alleviating the symptoms of steatohepatitis. The present study was designed to investigate the effects and mechanisms of action of puerarin in reducing lipid accumulation in oleic acid (OA)-treated HepG2 cells. Hepatocytes were treated with OA with or without puerarin to observe lipid accumulation by Oil Red O staining. We also examined hepatic lipid contents (e.g., triacylglycerol and cholesterol) following treatment with puerarin. Western blot analysis and reverse transcription-polymerase chain reaction (RT-PCR) were used to measure sterol regulatory element binding protein (SREBP)-1, fatty acid synthase (FAS), peroxisome proliferator-activated receptor α (PPARα) and adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) protein and mRNA expression, respectively. Our results revealed that puerarin suppressed OA-induced lipid accumulation, and reduced the triacylglycerol and cholesterol levels. Furthermore, puerarin decreased the expression levels of lipogenic enzymes, such as FAS and SREBPs, and increased the expression levels of PPARα, which are critical regulators of hepatic lipid metabolism through the AMPK signaling pathway. These results indicate that puerarin has the same ability to activate AMPK, and reduce SREBP-1 and FAS expression, thus inhibiting hepatic lipogenesis and increasing hepatic antioxidant activity. We found that puerarin exerted a regulatory effect on lipid accumulation by decreasing lipogenesis in hepatocytes. Therefore, puerarin extract may have therapeutic benefits in the treatment of fatty liver and lipid-related metabolic disorders.

View Figures

View References

1	Zhang S, Ji G and Liu J: Reversal of chemical-induced liver fibrosis in Wistar rats by puerarin. J Nutr Biochem. 17:485–491. 2006. View Article : Google Scholar : PubMed/NCBI
2	Yeung DK, Leung SW, Xu YC, Vanhoutte PM and Man RY: Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery. Eur J Pharmacol. 552:105–111. 2006. View Article : Google Scholar : PubMed/NCBI
3	Li Q, Xiao Y, Gong H, Shen D, Zhu F, Wu Q, Chen H and Zhong H: Effect of puerarin on the expression of extracellular matrix in rats with streptozotocin-induced diabetic nephropathy. Natl Med J India. 22:9–12. 2009.PubMed/NCBI
4	Guerra MC, Speroni E, Broccoli M, Cangini M, Pasini P, Minghett A, Crespi-Perellino N, Mirasoli M, Cantelli-Forti G and Paolini M: Comparison between Chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effects on rat liver CYP-catalysed drug metabolism. Life Sci. 67:2997–3006. 2000. View Article : Google Scholar
5	Yan LP, Chan SW, Chan AS, Chen SL, Ma XJ and Xu HX: Puerarin decreases serum total cholesterol and enhances thoracic aorta endothelial nitric oxide synthase expression in diet-induced hypercholesterolemic rats. Life Sci. 79:324–330. 2006. View Article : Google Scholar : PubMed/NCBI
6	Han RM, Tian YX, Becker EM, Andersen ML, Zhang JP and Skibsted LH: Puerarin and conjugate bases as radical scavengers and antioxidants: molecular mechanism and synergism with beta-carotene. J Agric Food Chem. 55:2384–2391. 2007. View Article : Google Scholar : PubMed/NCBI
7	Zhao M, Du YQ, Yuan L and Wang NN: Protective effect of puerarin on acute alcoholic liver injury. Am J Chin Med. 38:241–249. 2010. View Article : Google Scholar : PubMed/NCBI
8	Yang X, Hu W, Zhang Q, Wang Y and Sun L: Puerarin inhibits C-reactive protein expression via suppression of nuclear factor kappaB activation in lipopolysaccharide-induced peripheral blood mononuclear cells of patients with stable angina pectoris. Basic Clin Pharmacol Toxicol. 107:637–642. 2010. View Article : Google Scholar : PubMed/NCBI
9	Kim KM, Jung DH, Jang DS, Kim YS, Kim JM, Kim HN, Surh YJ and Kim JS: Puerarin suppresses AGEs-induced inflammation in mouse mesangial cells: a possible pathway through the induction of heme oxygenase-1 expression. Toxicol Appl Pharmacol. 244:106–113. 2010. View Article : Google Scholar : PubMed/NCBI
10	Zheng P, Ji G, Ma Z, Liu T, Xin L, Wu H, Liang X and Liu J: Therapeutic effect of puerarin on non-alcoholic rat fatty liver by improving leptin signal transduction through JAK2/STAT3 pathways. Am J Chin Med. 37:69–83. 2009. View Article : Google Scholar : PubMed/NCBI
11	Singh AK, Jiang Y, Benlhabib E and Gupta S: Herbal mixtures consisting of puerarin and either polyenylphosphatidylcholine or curcumin provide comprehensive protection against alcohol-related disorders in P rats receiving free choice water and 15% ethanol in pure water. J Med Food. 10:526–542. 2007. View Article : Google Scholar : PubMed/NCBI
12	Xiong FL, Sun XH, Gan L, Yang XL and Xu HB: Puerarin protects rat pancreatic islets from damage by hydrogen peroxide. Eur J Pharmacol. 529:1–7. 2006. View Article : Google Scholar
13	Cheng YF, Zhu GQ, Wang M, Cheng H, Zhou A, Wang N, Fang N, Wang XC, Xiao XQ, Chen ZW and Li QL: Involvement of ubiquitin proteasome system in protective mechanisms of puerarin to MPP(+)-elicited apoptosis. Neurosci Res. 63:52–58. 2009. View Article : Google Scholar
14	Bo J, Ming BY, Gang LZ, Lei C and Jia AL: Protection by puerarin against MPP⁺-induced neurotoxicity in PC12 cells mediated by inhibiting mitochondrial dysfunction and caspase-3-like activation. Neurosci Res. 53:183–188. 2005. View Article : Google Scholar : PubMed/NCBI
15	Xu X and Zheng X: Potential involvement of calcium and nitric oxide in protective effects of puerarin on oxygen-glucose deprivation in cultured hippocampal neurons. J Ethnopharmacol. 113:421–426. 2007. View Article : Google Scholar : PubMed/NCBI
16	Mercer LD, Kelly BL, Horne MK and Beart PM: Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures. Biochem Pharmacol. 69:339–345. 2005. View Article : Google Scholar : PubMed/NCBI
17	Chung MJ, Sung NJ, Park CS, Kweon DK, Mantovani A, Moon TW, Lee SJ and Park KH: Antioxidative and hypocholesterolemic activities of water-soluble puerarin glycosides in HepG2 cells and in C57 BL/6J mice. Eur J Pharmacol. 578:159–170. 2008. View Article : Google Scholar
18	Angulo P: Nonalcoholic fatty liver disease. N Engl J Med. 346:1221–1231. 2002. View Article : Google Scholar : PubMed/NCBI
19	American Gastroenterology Association: American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease. Gastroenterology. 123:1702–1704. 2002. View Article : Google Scholar : PubMed/NCBI
20	Koteish A and Diehl AM: Animal models of steatosis. Semin Liver Dis. 21:89–104. 2001. View Article : Google Scholar : PubMed/NCBI
21	Satia-Abouta J, Patterson RE, Schiller RN and Kristal AR: Energy from fat is associated with obesity in U.S. men: results from the Prostate Cancer Prevention Trial. Prev Med. 34:493–501. 2002. View Article : Google Scholar : PubMed/NCBI
22	Shimano H, Yahagi N, Amemiya-Kudo M, Hasty AH, Osuga J, Tamura Y, Shionoiri F, Iizuka Y, Ohashi K, Harada K, Gotoda T, Ishibashi S and Yamada N: Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem. 274:35832–35839. 1999. View Article : Google Scholar : PubMed/NCBI
23	Aggarwal BB: Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr. 30:173–199. 2010. View Article : Google Scholar : PubMed/NCBI
24	Brown MS and Goldstein JL: The SREBP pathway:regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 89:331–340. 1997. View Article : Google Scholar : PubMed/NCBI
25	Berger JP, Akiyama TE and Meinke PT: PPARs: therapeutic targets for metabolic disease. Trends Pharmacol Sci. 26:244–251. 2005. View Article : Google Scholar : PubMed/NCBI
26	Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ and Moller DE: Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 108:1167–1174. 2001. View Article : Google Scholar : PubMed/NCBI
27	You M, Matsumoto M, Pacold CM, Cho WK and Crabb DW: The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology. 127:1798–1808. 2004. View Article : Google Scholar : PubMed/NCBI
28	Friedman SL: Mechanisms of hepatic fibrogenesis. Gastroenterology. 134:1655–1669. 2008. View Article : Google Scholar : PubMed/NCBI
29	Tsukamoto H, She H, Hazra S, Cheng J and Miyahara T: Anti-adipogenic regulation underlies hepatic stellate cell trans-differentiation. J Gastroenterol Hepatol. 21(Suppl 3): S102–S105. 2006. View Article : Google Scholar
30	Kang OH, Kim SB, Seo YS, Joung DK, Mun SH, Choi JG, Lee YM, Kang DG, Lee HS and Kwon DY: Curcumin decreases oleic acid-induced lipid accumulation via AMPK phosphorylation in hepatocarcinoma cells. Eur Rev Med Pharmacol Sci. 17:2578–2586. 2013.PubMed/NCBI
31	Shao W, Yu Z, Chiang Y, Yang Y, Chai T, Foltz W, Lu H, Fantus IG and Jin T: Puerarin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS One. 7:e287842012. View Article : Google Scholar
32	Roche H, Zampelas A, Knapper JM, Webb D, Brooks C, Jackson KG, Wright JW, Gould BJ, Kafatos A, Gibney MJ and Williams CM: Effect of long-term olive oil dietary intervention on postprandial triacylglycerol and factor VII metabolism. Am J Clin Nutr. 68:552–560. 1998.PubMed/NCBI
33	Moreno JJ and Mitjavila MT: The degree of unsaturation of dietary fatty acids and the development of atherosclerosis (review). J Nutr Biochem. 14:182–189. 2003. View Article : Google Scholar : PubMed/NCBI
34	Kirimlioglu V, Kirimlioglu H, Yilmaz S, Ozgor D, Coban S, Karadag N and Yologlu S: Effect of fish oil, olive oil, and vitamin E on liver pathology, cell proliferation, and antioxidant defense system in rats subjected to partial hepatectomy. Transplant Proc. 38:564–567. 2006. View Article : Google Scholar : PubMed/NCBI
35	Winder WW and Hardie DG: AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol. 277:E1–E10. 1999.PubMed/NCBI
36	Brooks SC III, Brooks JS, Lee WH, Lee MG and Kim SG: Therapeutic potential of dithiolethiones for hepatic diseases. Pharmacol Ther. 124:31–43. 2009. View Article : Google Scholar : PubMed/NCBI
37	Hwang JT, Park IJ, Shin JI, Lee YK, Lee SK, Baik HW, Ha J and Park OJ: Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun. 338:694–699. 2005. View Article : Google Scholar : PubMed/NCBI
38	Auger C, Teissedre PL, Gerain P, Lequeux N, Bornet A, Serisier S, Besançon P, Caporiccio B, Cristol JP and Rouanet JM: Dietary wine phenolics catechin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation. J Agric Food Chem. 53:2015–2021. 2005. View Article : Google Scholar : PubMed/NCBI
39	Weng MS, Ho CT, Ho YS and Lin JK: Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling. Toxicol Appl Pharmacol. 218:107–118. 2007. View Article : Google Scholar